Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Treatment in Puberty for Klinefelter Syndrome
NCT06294990Phase 4Recruiting
- Start
- Aug 2024
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Testosterone TEPI patch in Klinefelter syndrome (KS) (2 arms). Primary endpoint: Changes in body fat mass at 2 years. Started Aug 2024; status: recruiting.
02
Drugs
Testosterone TEPI patch
03
Conditions
Klinefelter syndrome (KS)
Beyond the preview
Go deeper on NCT06294990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06294990.